Management of an Acinetobacter baumannii outbreak in an intensive care unit

Antunes, 2014, Acinetobacter baumannii: evolution of a global pathogen, Pathog Dis, 71, 292, 10.1111/2049-632X.12125 Naas, 2006, VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France, Emerg Infect Dis, 12, 1214, 10.3201/eid1708.051547 Vaux, 2012, Signalement des infections nosocomiales à Acinetobacter baumannii résistant à l’imipénème, France, août 2001–mai 2011, Bull Epid Heb, 31 Ministère de la santé de la jeunesse et des sports, 2007 Grammatico-Guillon, 2009, Relationship between the prevalence of methicillin resistant staphylococcus aureus infection and indicators of nosocomial infection control measures: a population based study in French hospitals, Infect Control Hosp Epidemiol, 30, 861, 10.1086/599774 Pittet, 2000, Effectiveness of a hospital-wide programme to improve compliance with hand hygiene, Lancet, 356, 1307, 10.1016/S0140-6736(00)02814-2 Flandrois, 1997, 210 Levin, 2001, Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit, Infect Control Hosp Epidemiol, 22, 717, 10.1086/501852 Falagas, 2007, Attributable mortality of Acinetobacter baumannii: no longer a controversial issue, Crit Care, 11, 134, 10.1186/cc5911 Falagas, 2006, Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies, Crit Care, 10, R48, 10.1186/cc4869 Naas, 2008, Diffusion de Acinetobacter baumannii multirésistant dans les établissements de santé : situation actuelle en France et mesures de contrôle, Hygienes, 6, 481 Kac, 2007, Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria, Arch Intern Med, 167, 2086, 10.1001/archinte.167.19.2086